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through the ﬁrst assessment following a CV event were retained.
Patients who experienced multiple events or died prior to the
next EQ-5D assessment were excluded from the main analysis.
Random-effects regression models, speciﬁed with random inter-
cepts and slopes, were used to model linear trajectories of utility
weights and VAS scores across time. To evaluate the impact of a
CV event (hospitalization for heart failure, recurrent acute myo-
cardial infarction, stroke, and resuscitated sudden death/cardiac
arrest), the mean trajectory change between the observed HRQL
scores following the CV event and the expected HRQL scores
based on the patients’ pre-event trajectories were estimated.
RESULTS: Among 14,703 adult patients enrolled in VALIANT,
2,556 patients were eligible for HRQL sub-study and completed
baseline EQ5D. Among the 504 patients who experienced a
nonfatal CV event, the trajectory-adjusted mean change follow-
ing the event was -0.07 (95%CI: -0.1 to -0.03; P = 0.0007)
based on UK utility weights, -0.05 (95%CI: -0.08 to -0.01;
P = 0.0082) based on US utility weights, and -0.06 (95%CI:
-0.08 to -0.03; P < 0.0001) based on VAS scores. Differences
between results using utility weights and VAS scores were most
notable for patients suffering a non-fatal stroke with trajectory
adjusted mean change scores of -0.26 with UK utility weights,
-0.22 with US utility weights, and -0.06 with VAS. CONCLU-
SION: Post-MI patients who suffered a subsequent cardiovascu-
lar event experienced a signiﬁcant decrease in HRQL.
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OBJECTIVE: Our aims were: 1) to determine whether proxy
responses to generic health related quality of life (HRQL) mea-
sures are responsive to meaningful patient improvement in the
six months following ischemic stroke; 2) to compare the respon-
siveness of generic measures by proxy assessment; and 3) to
compare proxy to patient responsiveness. METHODS: This sec-
ondary analysis of a longitudinal cohort study of ischemic stroke
patients and caregivers (n = 124 at baseline; n = 98 at 6 months)
included the following HRQL measures: EQ-5D Index, EQ-5D
VAS, HUI2, HUI3, and SF-6D. Patients were categorized as
improved from baseline to 6 months based on improvement in
Barthel Index (BI) categories (mild: 85; moderate: 60 to <85;
severe: <60). Responsiveness was compared on the basis of effect
size (ES) statistics for the baseline to 6 month interval. RESULTS:
Stroke patients were primarily male (52%), average 67 (SD 15)
years, and had primarily severe stroke (59% categorized as
severe by BI). Proxies tended to be female (67%) and either a
spouse (48%) or child (32%) of the stroke patient. Among
patients who improved according to the BI, all proxy-assessed
measures demonstrated large magnitudes of change (ES > 0.80).
The SF-6D was the most responsive measure (ES = 1.36; boot-
strapped 95% CI: 0.95–1.89), while the HUI3 was least respon-
sive (ES = 0.99, bootstrapped 95% CI: 0.69–1.40), although
bootstrapped 95% CIs overlapped for all measures. ES estimates
were not signiﬁcantly different for proxy raters compared to
patient self-report (all bootstrapped CIs overlapped). However,
the ES for proxy-rated VAS scores was 50% greater than patient
report while indirect utility measures tended to produce compa-
rable levels of responsiveness or were larger according to patient
self-report. CONCLUSION: Proxy assessments of stroke
patients were responsive to meaningful change using the VAS,
EQ-5D, SF-6D, HUI2, and HUI3 during the initial post-stroke
recovery process, capturing large magnitudes of changes similar
to patient assessments.
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OBJECTIVE: To study clinical determinants of satisfaction and
health-related quality of life (HRQoL) in patients with cardiac
disease and dyslipidemia. METHODS: A prospective, cross sec-
tional study was conducted using a questionnaire. The ques-
tionnaire containing SF-12v1 general health survey (range
0–100), the MacNew Heart disease health-related quality of life
instrument (range 1–7), and questions regarding satisfaction
with care (range 1–7) and demographics were administered to
randomly selected patients seeking care in a secondary preven-
tion lipid clinic. A unique de-identiﬁed patient code was
matched with medical charts to obtain clinical information.
Descriptive analyses and stepwise regression analyses were con-
ducted to assess study objectives. RESULTS: A total of 124
participants (65.7% male) completed the survey; response rate
was 72.9%. Physical (PCS) and mental (MCS) component
summary scores of the SF-12v1 scale were 37.3 (  9.2) and
49.1 (  9.7), respectively. The scores of the MacNew scale
domains were physical (5.2  1.3), emotional (5.2  0.9),
social (5.5  1.3), and global (5.2  1.0), respectively. In
general, the participants in the study were satisﬁed with the
care provided (4.28  0.62). Multivariate analysis indicated
that LDL levels (b = -0.37) and triglycerides levels (b = -0.26)
signiﬁcantly (p < 0.05) predicted the MCS scores, while drug
type (b = -0.51) and gender (b = -0.32) signiﬁcantly (p < 0.05)
predicted PCS scores. With respect to the MacNew scale, LDL
levels (b = -0.29), triglycerides (b = -0.22), and diastolic blood
pressure (b = 0.28) signiﬁcantly (p < 0.05) predicted emotional
scores, while drug type (b = -0.26) signiﬁcantly (p < 0.05) pre-
dicted physical scores. Further, LDL goals achieved (b = 0.22)
and BMI (b = -0.27) signiﬁcantly (p < 0.05) predicted satisfac-
tion with care. CONCLUSION: Results suggest that LDL
levels, triglycerides levels, and drug type used signiﬁcantly
affected HRQoL as measured by both scales and LDL goals
achieved BMI signiﬁcantly affected satisfaction with care. This
information is valuable for future interventional studies aiming
to improve HRQoL and satisfaction with care provided after
cardiac disease and may aid physicians’ decisions while provid-
ing care.
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OBJECTIVE: A major goal of a new anticoagulant therapy is to
alleviate the burden associated with treatment by Vitamin K
Antagonist (VKA). However, advantages such as simpliﬁed
administration and monitoring or reduced lifestyle constraints
A206 Abstracts
